Stoneridge Investment Partners’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

Stoneridge Investment Partners’s Portfolio PLXP Stock Details PLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-1,289	Closed	-$98K	–	338
2016 Q1	$98K	Sell	1,289 -579	-31%	-$36.8K	0.01%	283
2015 Q4	$167K	Sell	1,868 -285	-13%	-$27.3K	0.02%	264
2015 Q3	$241K	Sell	2,153 -25	-1%	-$2.88K	0.03%	251
2015 Q2	$222K	Buy	2,178 +683	+46%	+$70.7K	0.03%	256
2015 Q1	$163K	Buy	1,495 +82	+6%	+$8.4K	0.02%	252
2014 Q4	$129K	Buy	+1,413	New	+$121K	0.02%	245
2014 Q2	–	Sell	-1,250	Closed	-$101K	–	254
2014 Q1	$101K	Buy	+1,250	New	+$115K	0.02%	202

Other funds holding PLXP

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

TCP

Tourbillon Capital Partners New York $6.26M AUM 42.29% 1-Year Est. Return

LSVM

Lone Star Value Management Old Greenwich, Connecticut $52.7M AUM 30.18% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LOAMU

Lombard Odier Asset Management (USA) New York $957M AUM 35.8% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Emerald Acquisition Seattle, Washington $51.8B AUM

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

TCM

Timpani Capital Management Milwaukee, Wisconsin $209M AUM 62.15% 1-Year Est. Return

Stoneridge Investment Partners's PLXP Position: Q2 2016 in Review

Stoneridge Investment Partners sold out of PLx Pharma Inc. Common Stock (PLXP) in Q2 2016, closing a stake of 1,289 shares — an estimated $98K sold.

Stoneridge Investment Partners first reported a position in PLXP in Q1 2014 and held it in 7 quarters. The position peaked at $241K in Q3 2015. 33 funds tracked by Wall St. Rank hold PLXP as of Q2 2016.

Stoneridge Investment Partners reported no remaining PLx Pharma Inc. Common Stock position as of Q2 2016 after selling out during the quarter.
Stoneridge Investment Partners sold 1,289 PLx Pharma Inc. Common Stock shares in Q2 2016, an estimated $98K.
Stoneridge Investment Partners first reported a position in PLx Pharma Inc. Common Stock in Q1 2014 and held it in 7 quarters.
Stoneridge Investment Partners's PLx Pharma Inc. Common Stock position peaked at $241K in Q3 2015.
33 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q2 2016.

Based on Stoneridge Investment Partners's 13F filing for Q2 2016, filed 25 Jul 2016.